Skip to Main content Skip to Navigation

Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups

Document type :
Journal articles
Complete list of metadatas

Cited literature [11 references]  Display  Hide  Download

https://hal.univ-lorraine.fr/hal-01666834
Contributor : Ngere Ul <>
Submitted on : Monday, February 3, 2020 - 4:42:29 PM
Last modification on : Saturday, February 15, 2020 - 1:43:35 AM

File

Response to rituximab in B-CLL...
Publisher files allowed on an open archive

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Anne-Laure Gagez, Émilie Tuaillon, R Cezar, Caroline Dartigeas, B Mahé, et al.. Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups. Blood Cancer Journal, Nature Publishing Group, 2016, 6 (1), ⟨10.1038/bcj.2015.115⟩. ⟨hal-01666834⟩

Share

Metrics

Record views

495

Files downloads

52